$Hims & Hers Health (HIMS.US)$ Analysis of the sharp drop in...
Analysis of the sharp drop in stock prices, there was a triple punch.
Just before the third quarter, $HIMS dropped by 16% in response to 1) $LLY's significant underperformance in GLP-1 revenue, 2) $LLY accelerating the resolution of GLP-1 shortage by cooperating with $NVO, and 3) the announcement by the US FDA that the minimum dose of $NVO's weight-loss drug is now available. Friday is the employment statistics, Tuesday is the presidential election, and Monday is the earnings reports. I'll increase the number of shares a bit more.
I look forward to Monday. Let's beat it.
Just before the third quarter, $HIMS dropped by 16% in response to 1) $LLY's significant underperformance in GLP-1 revenue, 2) $LLY accelerating the resolution of GLP-1 shortage by cooperating with $NVO, and 3) the announcement by the US FDA that the minimum dose of $NVO's weight-loss drug is now available. Friday is the employment statistics, Tuesday is the presidential election, and Monday is the earnings reports. I'll increase the number of shares a bit more.
I look forward to Monday. Let's beat it.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
